Xianwei Zhang Selected Research

Neoplasms (Cancer)

4/2024	PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study.
4/2024	Advances in liposomes loaded with photoresponse materials for cancer therapy.
3/2024	Corrigendum to "Multi-target meridians classification based on the topological structure of anti-cancer phytochemicals using deep learning" [J. Ethnopharmacol. 319, Part 2, (30 January 2024), 117244].
1/2024	An APE1 gated signal amplified biosensor driven by catalytic hairpin assembly for the specific imaging of microRNA in situ.
1/2024	Multi-target meridians classification based on the topological structure of anti-cancer phytochemicals using deep learning.
10/2023	Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy.
1/2023	High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma.
1/2022	A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma.
6/2021	LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
1/2021	Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianwei Zhang Research Topics

Disease

21	Pain (Aches) 01/2024 - 04/2011
15	Neoplasms (Cancer) 04/2024 - 01/2017
11	Postoperative Pain 01/2024 - 02/2013
7	Hereditary Sensory and Autonomic Neuropathies (HSAN) 11/2022 - 05/2015
6	Inflammation (Inflammations) 12/2022 - 12/2015
4	Neuralgia (Stump Neuralgia) 01/2024 - 01/2020
4	Hyperalgesia 01/2024 - 01/2018
4	Infections 01/2023 - 12/2016
4	COVID-19 11/2022 - 10/2020
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2018
3	Chronic Pain 06/2023 - 01/2020
2	Hepatoblastoma 04/2024 - 08/2022
2	Acute Pain 01/2024 - 11/2021
2	Neuroinflammatory Diseases 01/2024 - 01/2024
2	Thrombosis (Thrombus) 10/2023 - 10/2023
2	Neoplasm Metastasis (Metastasis) 10/2023 - 11/2020
2	Neuroblastoma 01/2023 - 01/2021
2	Carcinogenesis 06/2021 - 01/2017
2	Hypersensitivity (Allergy) 01/2020 - 01/2020
2	Atherosclerosis 06/2016 - 12/2015
1	Hemangioendothelioma 04/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023
1	Cognitive Dysfunction 12/2023
1	Psychomotor Agitation (Akathisia) 10/2023
1	Cushing Syndrome 10/2023
1	Adrenocortical Carcinoma 10/2023
1	Precocious Puberty 10/2023
1	Pediatric Adrenocortical Carcinoma 10/2023
1	Heart Failure 07/2023
1	Cardiac Arrhythmias (Arrythmia) 07/2023
1	Atrial Fibrillation 07/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Sepsis (Septicemia) 12/2022
1	Pneumonia (Pneumonitis) 12/2022
1	Lung Injury 12/2022
1	Autism Spectrum Disorder 11/2022
1	Bites and Stings (Sting) 10/2022
1	Multiple Myeloma 09/2022
1	Postherpetic Neuralgia 09/2022
1	Herpes Zoster 09/2022
1	Breakthrough Infections 01/2022

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2018
6	3-(2-carboxyindol-3-yl)propionic acidIBA 11/2022 - 05/2015
6	Analgesics (Analgesic Drugs)IBA 01/2021 - 02/2013
5	Biomarkers (Surrogate Marker)IBA 08/2022 - 12/2015
4	Sufentanil (Sufenta)FDA LinkGeneric 10/2023 - 02/2015
4	Sodium Channels (Sodium Channel)IBA 06/2023 - 01/2016
3	Circular RNAIBA 01/2018 - 01/2018
2	PhytochemicalsIBA 03/2024 - 01/2024
2	CytokinesIBA 01/2024 - 01/2021
2	Opioid Analgesics (Opioids)IBA 10/2023 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2023 - 09/2022
2	VaccinesIBA 11/2022 - 01/2022
2	COVID-19 VaccinesIBA 11/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2021
2	Amino Acids FDA Link 01/2020 - 06/2016
2	Tramadol (K315)FDA LinkGeneric 01/2018 - 02/2015
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2024
1	Vitamin K FDA Link 04/2024
1	acarboxyprothrombin (PIVKA)IBA 04/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024
1	Liposomes (Liposome)IBA 04/2024
1	MicroRNAs (MicroRNA)IBA 01/2024
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2024
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2024
1	Histones (Histone)IBA 01/2024
1	Small Interfering RNA (siRNA)IBA 01/2024
1	ManganeseIBA 12/2023
1	Hormones (Hormone)IBA 10/2023
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2023
1	aminoacylase I (aminoacylase)IBA 06/2023
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2022
1	piperlongumineIBA 12/2022
1	FibrinIBA 12/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2022
1	InterferonsIBA 10/2022
1	Lenalidomide (CC 5013)FDA Link 09/2022
1	Long Noncoding RNAIBA 01/2022
1	CopperIBA 01/2022

Therapy/Procedure

8	Analgesia 01/2024 - 02/2013
6	Therapeutics 04/2024 - 01/2017
4	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2018 - 04/2011
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 12/2015
3	Aftercare (After-Treatment) 09/2022 - 01/2012
2	Drug Therapy (Chemotherapy) 04/2024 - 10/2023
2	Meridians (Jing Luo) 03/2024 - 01/2024
2	Cesarean Section (Caesarean Section) 12/2020 - 01/2018
2	Gynecologic Surgical Procedures (Gynecologic Surgery) 09/2017 - 10/2015
1	Photothermal Therapy 04/2024
1	Radiotherapy 04/2024
1	Phototherapy (Light Therapy) 04/2024
1	Photochemotherapy (Photodynamic Therapy) 04/2024
1	Spinal Injections 01/2024
1	Thoracotomy 10/2023
1	Neoadjuvant Therapy 10/2023
1	Spinal Cord Stimulation 09/2022
1	Fecal Microbiota Transplantation 11/2021